“You may choose to look the other way, but you can never say again that you did not know.”
— William Wilberforce
The supply of emergency use authorization (EUA) COVID-19 vaccines in the United States is initially expected to be limited and the U.S. Centers for Disease Control and Prevention (CDC) has provided recommendations to federal, state and local governments about who should be vaccinated first.1 The Advisory Committee on Immunization Practices (ACIP) has recommended that healthcare […]
Between Dec. 11 and 18, 2020, the U.S. Food and Drug Administration (FDA) granted Pfizer/BioNTech and Moderna pharmaceutical companies an Emergency Use Authorization (EUA)1 to distribute COVID-19 vaccines using messenger RNA (mRNA) technology that to date has not been licensed for use in humans.2 3 4 5 Although the Advisory Committee on Immunization Practices (ACIP) […]
A U.S. advisory panel says the first doses of a COVID-19 vaccine should be given to health care workers and residents of long-term care facilities. The Advisory [Committee] on Immunization Practices advises the Centers for Disease Control and voted Tuesday that, with initial doses expected to be scarce, frontline health workers are a top priority. […]
The chief scientist for the U.S. government’s Operation Warp Speed (OWS) program aimed at facilitating development of COVID-19 vaccines confirmed on Dec. 1, 2020 that 10-15 percent of the volunteers, who participated in clinical trials to test the safety and effectiveness of experimental vaccines developed by Pfizer, Inc. (in partnership with BioNTech SE) and Moderna, […]
Opinion | On Oct. 7, 2020, during a hastily scheduled virtual meeting,1 four District of Columbia Council members making up the Health Committee2 amended and unanimously passed a minor consent bill, B23-0171.3 The bill would not only permit children aged 11 years and older to give consent for doctors and other vaccine administrators to give them […]
The Advisory Committee on Immunization Practices (ACIP) for the U.S. Centers for Disease Control and Prevention (CDC) has issued new updates for influenza vaccines for 2020–2021 “flu season,” primarily for Fluzone and Fluad vaccines. In November 2019, U.S. Food and Drug Administration (FDA) licensed inactivated injectable Fluzone High-Dose Quadrivalent (HD-IIV4) for use in persons aged […]
Virginia’s Commissioner of Health Dr. Norman Oliver, MD said on Aug. 21, 2020 that he intends to mandate COVID-19 vaccinations for all residents of Virginia as soon as a vaccine is available. “[Coronavirus] is killing people now, we don’t have a treatment for it and if we develop a vaccine that can prevent it from […]
Under an amendment to the Public Readiness and Emergency Preparedness Act (PREP), pharmacists and pharmacy interns in the United States are now permitted to administer vaccines recommended by the Centers for Disease Control and Prevention (CDC) to children over three years of age.1 Currently, there are 28 states that allow pharmacists to administer vaccinations to […]
Story Highlights Most countries that have supply contracts with AstraZeneca have granted the drug company liability protection for their COVID-19 vaccine. In the U.S., vaccine manufacturers and administrators are shielded from liability under the PREP Act of 2005 for a vaccine or drug that is developed in response to a declared public health emergency, including […]
The American Cancer Society (ACS) updated its guidelines for human papilloma virus (HPV) vaccination on July 8, 2020 and now recommends that doctors and other healthcare providers routinely administer the two-dose HPV vaccination series to boys and girls between the ages of nine and 10.1 Currently, the federal Advisory Committee on Immunization Practices (ACIP) recommends […]